December 2007
Gut;Dec2007, Vol. 56 Issue 12, p1800
Academic Journal
Correction notice
A correction to the article "Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD" that was previously published is presented.


Related Articles

  • Symptoms, causes and cures.  // Current Health 2;Dec86, Vol. 13 Issue 4, p14 

    Physiology and function of the liver. Diseases of the liver are described as to symptoms, cause and cure. Cirrhosis; Hepatitis-A; Hepatitis-B; Biliary atresia.

  • Leapin' livers!  // Current Health 1;Feb1992, Vol. 15 Issue 6, p2 

    Reports that a doctor at Baylor College of Medicine in Texas is trying to transplant healthy cells from donated livers into children with liver disease. Discusses doctors' hopes regarding the procedure.

  • Scarring in alcoholic liver disease. Friedman, Scott L. // Alcohol Health & Research World;1997, Vol. 21 Issue 4, p310 

    Presents information on how the liver responds to scar formation, such as fibrosis. Role played by stellate cells in the development of liver fibrosis; Identity of changes which can cause liver failure; How to recognize liver fibrosis; Cellular and molecular features of stellate cell...

  • Needle-sharing is greater hepatitis risk than sex.  // Addiction Letter;Nov95, Vol. 11 Issue 11, p6 

    Reports that hepatitis B, a fatal viral infection cause by unsafe sex but spread easily by intravenous drug users sharing needles. Hepatitis C virus; Survey.

  • Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. Harrison, P.M.; Wendon, J.A. // New England Journal of Medicine;6/27/91, Vol. 324 Issue 26, p1852 

    Presents a study that was undertaken to determine the effect of acetylcysteine on systemic hemodynamics and oxygen transport in 12 patients with acetaminophen-induced fulminant hepatic failure and 8 patients with acute liver failure from other causes. Background; Methods; Results; Conclusions.

  • When and how to screen for liver disease.  // Patient Care;9/30/1998, Vol. 32 Issue 15, p19 

    Provides information on the screening of chronic liver diseases in persons. When should a person be screened for chronic diseases; Details on chronic liver disease being the eighth leading cause of death in the United States; Different types of chronic liver diseases; Treatment procedures for...

  • At last-a competence framework for liver disease. Clayton, Michelle // Gastrointestinal Nursing;Feb2013, Vol. 11 Issue 1, p5 

    The author reflects on the launch of new guidelines called "Caring for People with Liver Diseases: A Competence Framework for Nursing" developed by specialist liver nurses. She mentions that age is no barrier to liver disease and these guidelines will help in raising awareness of risk factors...

  • Patients on rezulin need hepatic monitoring. Cerrato, Paull L. // RN;Mar98, Vol. 61 Issue 3, p78 

    Presents information on why patient using troglitazone (Rezulin) should be monitored frequently for liver dysfunction. Information on reports from the Food and Drug Administration on liver injury; Reference to patients with symptoms of liver dysfunction, nausea, vomiting or jaundice and dark...

  • Framework developed for care of patients with liver disease.  // Primary Health Care;Mar2013, Vol. 23 Issue 2, p5 

    The article reports that the Royal College of Nursing (RCN) in collaboration with the National Health Services (NHS) has developed a competence framework aimed at nursing staff to empower them to identify the signs and risk factors of liver disease.

  • Chart correction.  // MLO: Medical Laboratory Observer;Dec2010, Vol. 42 Issue 12, p6 

    A letter to the editor is presented in response to the article "Unexpected Laboratory Diagnosis: Acquired Dysfibrinogenemia in a Bleeding Patient With Liver Disease," that was published in the October, 2010 issue of the journal.


Read the Article


Sign out of this library

Other Topics